Intragastric Balloon Market 2028 By Product, Filling Material, End User | The Insight Partners

report image

Intragastric Balloon Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Single Gastric Balloon, Dual Gastric Balloon, Triple Gastric Balloon); Filling Material (Saline Filled, Gas Filled); End User (Hospitals, Ambulatory Surgical Centers, Clinics)

Report Code: TIPHE100001319 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Intragastric balloon is a medical device that is used in an endoscopic intragastrical procedure, in that procedure the inflated silicone balloon is inserted in the stomach for a span of months. This is also known as weight loss balloon that is designed to sense fullness, controls hunger, delays gastric emptying by altering gut hormones and peptides thus reducing food intake ultimately. This procedure is non-surgical, non-invasive, and requires no-incision.


The "Global Intragastric Balloon Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the intragastric balloon market with detailed market segmentation by product, filling material, end user, and geography. The report provides key statistics on the market status of the leading intragastric balloon market players and offers key trends and opportunities in the market.


  •   Based on product, the market is segmented as single gastric balloon, dual gastric balloon, and triple gastric balloon.
  •   Based on filling material, the market is segmented as saline filled and gas filled.
  •   Based on end user, the market is segmented as hospitals, ambulatory surgical centers, and clinics.



  •   Due to increase in the prevalence of obesity and growing awareness among the obese patients is likely to drive the intragastric ballon market. For instance, in the US, where around 40% of the population is reported to be obese.
  •   Additionally, increase in the number of surgeons trained in advance surgical techniques has driven the market of intragastric balloon in the recent days.
  •   Increasing demand of healthcare professionals across the world, and growing competitiveness are expected to offer growth opportunities for the players operating in the market.


  •   Side effects with the procedure, such as up to 2 weeks after the placement of the balloon device, the patient can have nausea, vomiting, stomach cramps, reflux, and other symptoms is likely to restraint the market growth.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The intragastric balloon market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the intragastric balloon market in these regions.

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. However, the intragastric balloon market is likely to positively impact COVID-19, as people with an underlying disease such as obesity are at even more major risk during the COVID-19 pandemic. It has been observed that through the COVID-19 situation the obesity had increased exponentially. As per an article printed by the European Journal of Nutrition in December 2020, obesity has doubled globally. Furthermore, as per the data published by the Center for Disease Control and Prevention in March 2021, it is predicted that around 30.2% of total COVID-19 hospitalizations were attributed to obesity.


The report covers key developments in the intragastric balloon market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from intragastric balloon market are anticipated to lucrative growth opportunities in the future with the rising demand for intragastric balloon in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the intragastric balloon market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Apollo Endosurgery, Inc.,
  •   Reshape Medical Inc.,
  •   Hélioscopie SA,
  •   Allurion Technologies Inc.,
  •   Spatz Fgia Inc.,
  •   Silimed,
  •   Obalon Therapeutics,
  •   Medsil,
  •   Baronova, Inc.
  •   Endalis.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. Apollo Endosurgery, Inc.,
2. Reshape Medical Inc.,
3. Hélioscopie SA,
4. Allurion Technologies Inc.,
5. Spatz Fgia Inc.,
6. Silimed,
7. Obalon Therapeutics,
8. Medsil,
9. Baronova, Inc.
10. Endalis.
11. Lexel Medical
12. Districlass Medical
13. Tulip Medical.
14. Life Partners Europe
15. Medicone
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount